The Gastrointestinal Therapeutics Market is expected to register a CAGR of 4.21% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The report is segmented by Type (Branded and Generics); Route of Administration (Oral, Intravenous, and Others); Application (Ulcerative Colitis, Crohn's Disease, Gastroesophageal Reflux Disease (GERD), and Other Applications), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies). The global analysis is broken down at the regional level and for major countries. The market evaluation is presented in US$ for the above segmental analysis.
Purpose of the ReportThe report Gastrointestinal Therapeutics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Gastrointestinal Therapeutics Market Segmentation
Type- Branded
- Generics
- Oral
- Intravenous
- Ulcerative Colitis
- Crohn's Disease
- Gastroesophageal Reflux Disease
- Hospital Pharmacies
- Retail Pharmacies and Online Pharmacies
Strategic Insights
Gastrointestinal Therapeutics Market Growth Drivers- Increasing Prevalence of Gastrointestinal Disorders: The rising prevalence of gastrointestinal (GI) disorders such as irritable bowel syndrome (IBS), Crohn’s disease, ulcerative colitis, and gastroesophageal reflux disease (GERD) is a significant driver in the gastrointestinal therapeutics market. Gastrointestinal disorders grow in numbers particularly IBS Crohn's disease ulcerative colitis and GERD drive market growth in gastrointestinal therapeutics. More people worldwide are developing lifestyle diseases which makes GI conditions spread faster which drives up demand for better treatment solutions. More people develop GI disorders each year because the elderly population and different eating patterns are rising. These changes make us need better medicines to treat these diseases. Experts predict the market for gastrointestinal therapeutics will grow rapidly because these health problems affect more people. Organizations work to create better medical solutions for long-term conditions so patients can experience better results. Patients recognize that GI disorders affect their life quality and now seek medical help for better treatment which expands market growth. Gastrointestinal therapeutics will see more market success because of new biologic and targeted treatments. As healthcare systems continue to address these growing needs, the gastrointestinal therapeutics market is positioned for substantial expansion.
- Advances in Biologic and Targeted Therapies: Gastrointestinal therapeutics are evolving through biologic and targeted treatments which create new business opportunities. These advanced treatments now help people with Crohn's disease and ulcerative colitis better control their chronic conditions. Biologics and small molecules that target disease-related molecules help doctors treat specific parts of the body in ways that traditional therapies cannot match. The market for gastrointestinal therapeutics should grow stronger thanks to precision medicine which provides better treatment options to patients previously unable to find relief. Biologic drugs will lead medical treatment in developed nations because many patients there already have access to these advanced therapies. Biologic and targeted treatments show better results for patients who stick to their treatment plans which expands their market share. The ongoing research and development in this area are expected to continue to fuel the growth of the gastrointestinal therapeutics market as new therapies are introduced.
- Rising Consumer Awareness and Healthcare Expenditure: Consumers now understand GI health better and governments spend more on healthcare which drives up demand for gastrointestinal medicines. More people seek medical help for their GI problems since they understand their symptoms better and have options for treatment. People now find medical help sooner because they get GI information from digital sources and education programs. Healthcare spending increases worldwide because more people join the middle class especially in developing nations. More money spent on healthcare lets patients buy both OTC and prescription drugs that treat their gastrointestinal problems. The need for better gastrointestinal treatments grows because people make more health investments. Market research shows gastrointestinal therapeutics will grow more popular because people and countries are paying greater attention to their digestive health. The market will expand because people are receiving more preventive care and better managing their chronic GI diseases which will increase the use of OTC and prescription gastrointestinal medicines.
- Growing Focus on Personalized Medicine for GI Disorders: Growing interest of the market toward customized medicine regarding gastrointestinal disorders This current market toward GI therapeutics provides more orientation on tailoring a treatment package according to every individual patient's condition. While treating a disease, medical groups look into various genetics from their genes and personal habits of disease-causing behavioral details about patients. The way it works helps to treat conditions effectively in such diseases as ulcerative colitis, Crohn's disease, and IBS with patients as co-researchers. The market data shows personal medicine will boost the market value of gastrointestinal therapeutics since doctors use it more often to treat patients. The new treatments are changing how doctors handle gastrointestinal conditions and will help these therapies gain more market share. Furthermore, as more patients seek individualized treatments, the need for targeted therapies that can address specific disease pathways will continue to rise.
- Rising Use of Digital Health Tools for GI Disease Management: The gastrointestinal therapeutics market now includes digital health tools like mobile apps, telemedicine and wearable devices as emerging treatment options. Digital tools help patients and doctors monitor gastrointestinal symptoms and medication use while tracking their food choices. Digital tools help connect patients better with their healthcare team and teach them more about their conditions. Digital health tools working with medical treatments will help people with GI conditions get better results from their treatment. The gastrointestinal therapeutics market will grow according to market forecasts because digital health technologies keep gaining acceptance. Digital health tools save money for healthcare providers and patients while making their medical care better. Digital health tools help researchers and clinicians access real-world patient data that improves how well treatments work. As technology continues to evolve, the role of digital health tools in the management of gastrointestinal diseases will likely become even more important.
- Expansion of Combination Therapies in GI Treatment: The gastrointestinal therapeutics market now often uses multiple drugs together for treatment. Combination therapies that use more than one medication or treatment method are being adopted because they can make therapy work better and protect patients from side effects. Patients with inflammatory bowel diseases like Crohn's disease and ulcerative colitis need multiple treatments that combine biologic agents with immunosuppressants and corticosteroids. These medical treatments work on multiple parts of the illness to help patients manage their symptoms better. Market projections show combination therapies will fuel the expansion of gastrointestinal medicine over time. Healthcare providers will need to use more combined treatments because they provide better results. Furthermore, these therapies offer the potential to reduce the burden of disease in patients, improve patient quality of life, and lower healthcare costs, making them an attractive option for both patients and pharmaceutical companies.
- Increasing Use of Gut Microbiome Modulation in Treatment: The gastrointestinal therapeutics market sees success in gut microbiome modulation treatments for GI disorders. Research proves that the gut microbiome manages digestive health and affects conditions including IBS, IBD, and liver disease. The microbiome can now be treated for digestive disorders by adding prebiotics, probiotics and FMT while following special diets to balance gut bacteria. When scientists learn more about how the microbiome affects digestion health experts expect greater use of therapies that control the microbiome. The microbiome market growth depends on businesses that develop microbiome therapies and research both established pharmaceutical firms and new startups. Research on the gut microbiome shows strong potential to develop new treatments for GI conditions which can expand into the market while creating individualized patient care.
- Expanding Probiotic and Prebiotic Market: The growth of probiotic and prebiotic products creates a large business potential for gastrointestinal therapeutic companies. People turn to probiotics and prebiotics because these products help manage their gastrointestinal issues including IBS constipation and diarrhea. More people now use natural treatments in both doctor-prescribed and OTC products. According to market research the segment that sells probiotics and prebiotics will expand quickly because people understand better how their gut health affects their total well-being. Companies that modify probiotics and prebiotics for unique GI conditions will gain more market share. As more research supports the efficacy of these products, both in clinical and consumer healthcare settings, the demand for these products will continue to rise, creating significant growth potential.
- Growing Market for Over-the-Counter (OTC) GI Products: The gastrointestinal therapeutics market offers great potential because customers buy more OTC medicines to treat their stomach problems. People take better care of their digestive health and want OTC solutions for treating everyday GI problems like acid reflux, constipation, and indigestion. People buy OTC products for digestive health because they are easy to find and use at affordable prices. Market analysts expect future growth in the OTC segment because people now prefer to treat their minor GI problems with self-care products. Emerging markets will see more OTC GI products available because healthcare systems are less advanced while people still need affordable treatments for their digestive issues. Pharmaceutical companies that focus on developing OTC gastrointestinal therapeutics stand to capture a larger market share, as more consumers seek out readily available solutions for their digestive health needs.
- Increasing Use of Gut Microbiome Modulation in Treatment: The gastrointestinal therapeutics market offers new possibilities through research into using the gut microbiome to treat various digestive system issues. Scientific studies confirm the microbiome manages gut health and affects IBS, IBD, and liver disease development. The microbiome can be adjusted with prebiotics, probiotics, FMT, and dietary changes to treat GI disorders by rebalancing gut bacteria. As researchers discover more about gut health and the microbiome market experts predict rising demand for treatments that adjust the microbiome balance. Companies looking to develop microbiome-based treatments will find new market opportunities and may work alongside pharmaceutical producers and small microbiome research businesses. The medical field will expand its GI treatment options and personalize patient care as scientists learn more about microbiome modulation.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Gastrointestinal Therapeutics Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Gastrointestinal Therapeutics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Gastrointestinal Therapeutics Market is estimated to witness a CAGR of 4.21% from 2025 to 2031.
The major factors driving the Gastrointestinal Therapeutics Market are Increasing Prevalence of Gastrointestinal Disorders, Advances in Biologic and Targeted Therapies, and Rising Consumer Awareness and Healthcare Expenditure.
Future trends in the Gastrointestinal Therapeutics Market are Growing Focus on Personalized Medicine for GI Disorders, Rising Use of Digital Health Tools for GI Disease Management, and Expansion of Combination Therapies in GI Treatment.
Some of the players operating in the market are Abbott, AbbVie Inc., ALLERGAN, AstraZeneca, Bayer AG, GlaxoSmithKline plc., Janssen Global Services, LLC, Pfizer Inc., Salix Pharmaceuticals, Takeda Pharmaceutical Company Limited
The report can be delivered in PDF/PPT format; we can also share an excel datasheet based on the request.
Some customization options available based on the request are an additional 3–5 company profiles and a country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation# as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Gastrointestinal Therapeutics Market - By Type
1.3.2 Gastrointestinal Therapeutics Market - By Route of Administration
1.3.3 Gastrointestinal Therapeutics Market - By Application
1.3.4 Gastrointestinal Therapeutics Market - By Distribution Channel
1.3.5 Gastrointestinal Therapeutics Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GASTROINTESTINAL THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GASTROINTESTINAL THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. GASTROINTESTINAL THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. GASTROINTESTINAL THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. GASTROINTESTINAL THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. GASTROINTESTINAL THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. BRANDED
7.3.1. Overview
7.3.2. Branded Market Forecast and Analysis
7.3.3. Aminosalicylates Market
7.3.3.1. Overview
7.3.3.2. Aminosalicylates Market Forecast and Analysis
7.3.4. Antacids Market
7.3.4.1. Overview
7.3.4.2. Antacids Market Forecast and Analysis
7.3.5. Enzyme Replacement Therapies Market
7.3.5.1. Overview
7.3.5.2. Enzyme Replacement Therapies Market Forecast and Analysis
7.3.6. Proton Pump Inhibitors Market
7.3.6.1. Overview
7.3.6.2. Proton Pump Inhibitors Market Forecast and Analysis
7.3.7. Laxatives Market
7.3.7.1. Overview
7.3.7.2. Laxatives Market Forecast and Analysis
7.3.8. Antiemetics Market
7.3.8.1. Overview
7.3.8.2. Antiemetics Market Forecast and Analysis
7.3.9. H2 Antagonists Market
7.3.9.1. Overview
7.3.9.2. H2 Antagonists Market Forecast and Analysis
7.3.10. Antidiarrheals Market
7.3.10.1. Overview
7.3.10.2. Antidiarrheals Market Forecast and Analysis
7.3.11. Biologics Market
7.3.11.1. Overview
7.3.11.2. Biologics Market Forecast and Analysis
7.3.12. Others Market
7.3.12.1. Overview
7.3.12.2. Others Market Forecast and Analysis
7.4. GENERICS
7.4.1. Overview
7.4.2. Generics Market Forecast and Analysis
8. GASTROINTESTINAL THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. INTRAVENOUS
8.4.1. Overview
8.4.2. Intravenous Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. GASTROINTESTINAL THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. ULCERATIVE COLITIS
9.3.1. Overview
9.3.2. Ulcerative Colitis Market Forecast and Analysis
9.4. CROHN'S DISEASE
9.4.1. Overview
9.4.2. Crohn's Disease Market Forecast and Analysis
9.5. GASTROESOPHAGEAL REFLUX DISEASE (GERD)
9.5.1. Overview
9.5.2. Gastroesophageal Reflux Disease (GERD) Market Forecast and Analysis
9.6. OTHER APPLICATIONS
9.6.1. Overview
9.6.2. Other Applications Market Forecast and Analysis
10. GASTROINTESTINAL THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
10.1. OVERVIEW
10.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
10.3. HOSPITAL PHARMACIES
10.3.1. Overview
10.3.2. Hospital Pharmacies Market Forecast and Analysis
10.4. RETAIL PHARMACIES
10.4.1. Overview
10.4.2. Retail Pharmacies Market Forecast and Analysis
10.5. ONLINE PHARMACIES
10.5.1. Overview
10.5.2. Online Pharmacies Market Forecast and Analysis
11. GASTROINTESTINAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Gastrointestinal Therapeutics Market Overview
11.1.2 North America Gastrointestinal Therapeutics Market Forecasts and Analysis
11.1.3 North America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Type
11.1.4 North America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Route of Administration
11.1.5 North America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Application
11.1.6 North America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Distribution Channel
11.1.7 North America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Countries
11.1.7.1 United States Gastrointestinal Therapeutics Market
11.1.7.1.1 United States Gastrointestinal Therapeutics Market by Type
11.1.7.1.2 United States Gastrointestinal Therapeutics Market by Route of Administration
11.1.7.1.3 United States Gastrointestinal Therapeutics Market by Application
11.1.7.1.4 United States Gastrointestinal Therapeutics Market by Distribution Channel
11.1.7.2 Canada Gastrointestinal Therapeutics Market
11.1.7.2.1 Canada Gastrointestinal Therapeutics Market by Type
11.1.7.2.2 Canada Gastrointestinal Therapeutics Market by Route of Administration
11.1.7.2.3 Canada Gastrointestinal Therapeutics Market by Application
11.1.7.2.4 Canada Gastrointestinal Therapeutics Market by Distribution Channel
11.1.7.3 Mexico Gastrointestinal Therapeutics Market
11.1.7.3.1 Mexico Gastrointestinal Therapeutics Market by Type
11.1.7.3.2 Mexico Gastrointestinal Therapeutics Market by Route of Administration
11.1.7.3.3 Mexico Gastrointestinal Therapeutics Market by Application
11.1.7.3.4 Mexico Gastrointestinal Therapeutics Market by Distribution Channel
11.2. EUROPE
11.2.1 Europe Gastrointestinal Therapeutics Market Overview
11.2.2 Europe Gastrointestinal Therapeutics Market Forecasts and Analysis
11.2.3 Europe Gastrointestinal Therapeutics Market Forecasts and Analysis - By Type
11.2.4 Europe Gastrointestinal Therapeutics Market Forecasts and Analysis - By Route of Administration
11.2.5 Europe Gastrointestinal Therapeutics Market Forecasts and Analysis - By Application
11.2.6 Europe Gastrointestinal Therapeutics Market Forecasts and Analysis - By Distribution Channel
11.2.7 Europe Gastrointestinal Therapeutics Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Gastrointestinal Therapeutics Market
11.2.7.1.1 Germany Gastrointestinal Therapeutics Market by Type
11.2.7.1.2 Germany Gastrointestinal Therapeutics Market by Route of Administration
11.2.7.1.3 Germany Gastrointestinal Therapeutics Market by Application
11.2.7.1.4 Germany Gastrointestinal Therapeutics Market by Distribution Channel
11.2.7.2 France Gastrointestinal Therapeutics Market
11.2.7.2.1 France Gastrointestinal Therapeutics Market by Type
11.2.7.2.2 France Gastrointestinal Therapeutics Market by Route of Administration
11.2.7.2.3 France Gastrointestinal Therapeutics Market by Application
11.2.7.2.4 France Gastrointestinal Therapeutics Market by Distribution Channel
11.2.7.3 Italy Gastrointestinal Therapeutics Market
11.2.7.3.1 Italy Gastrointestinal Therapeutics Market by Type
11.2.7.3.2 Italy Gastrointestinal Therapeutics Market by Route of Administration
11.2.7.3.3 Italy Gastrointestinal Therapeutics Market by Application
11.2.7.3.4 Italy Gastrointestinal Therapeutics Market by Distribution Channel
11.2.7.4 Spain Gastrointestinal Therapeutics Market
11.2.7.4.1 Spain Gastrointestinal Therapeutics Market by Type
11.2.7.4.2 Spain Gastrointestinal Therapeutics Market by Route of Administration
11.2.7.4.3 Spain Gastrointestinal Therapeutics Market by Application
11.2.7.4.4 Spain Gastrointestinal Therapeutics Market by Distribution Channel
11.2.7.5 United Kingdom Gastrointestinal Therapeutics Market
11.2.7.5.1 United Kingdom Gastrointestinal Therapeutics Market by Type
11.2.7.5.2 United Kingdom Gastrointestinal Therapeutics Market by Route of Administration
11.2.7.5.3 United Kingdom Gastrointestinal Therapeutics Market by Application
11.2.7.5.4 United Kingdom Gastrointestinal Therapeutics Market by Distribution Channel
11.2.7.6 Rest of Europe Gastrointestinal Therapeutics Market
11.2.7.6.1 Rest of Europe Gastrointestinal Therapeutics Market by Type
11.2.7.6.2 Rest of Europe Gastrointestinal Therapeutics Market by Route of Administration
11.2.7.6.3 Rest of Europe Gastrointestinal Therapeutics Market by Application
11.2.7.6.4 Rest of Europe Gastrointestinal Therapeutics Market by Distribution Channel
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Gastrointestinal Therapeutics Market Overview
11.3.2 Asia-Pacific Gastrointestinal Therapeutics Market Forecasts and Analysis
11.3.3 Asia-Pacific Gastrointestinal Therapeutics Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Gastrointestinal Therapeutics Market Forecasts and Analysis - By Route of Administration
11.3.5 Asia-Pacific Gastrointestinal Therapeutics Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Gastrointestinal Therapeutics Market Forecasts and Analysis - By Distribution Channel
11.3.7 Asia-Pacific Gastrointestinal Therapeutics Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Gastrointestinal Therapeutics Market
11.3.7.1.1 Australia Gastrointestinal Therapeutics Market by Type
11.3.7.1.2 Australia Gastrointestinal Therapeutics Market by Route of Administration
11.3.7.1.3 Australia Gastrointestinal Therapeutics Market by Application
11.3.7.1.4 Australia Gastrointestinal Therapeutics Market by Distribution Channel
11.3.7.2 China Gastrointestinal Therapeutics Market
11.3.7.2.1 China Gastrointestinal Therapeutics Market by Type
11.3.7.2.2 China Gastrointestinal Therapeutics Market by Route of Administration
11.3.7.2.3 China Gastrointestinal Therapeutics Market by Application
11.3.7.2.4 China Gastrointestinal Therapeutics Market by Distribution Channel
11.3.7.3 India Gastrointestinal Therapeutics Market
11.3.7.3.1 India Gastrointestinal Therapeutics Market by Type
11.3.7.3.2 India Gastrointestinal Therapeutics Market by Route of Administration
11.3.7.3.3 India Gastrointestinal Therapeutics Market by Application
11.3.7.3.4 India Gastrointestinal Therapeutics Market by Distribution Channel
11.3.7.4 Japan Gastrointestinal Therapeutics Market
11.3.7.4.1 Japan Gastrointestinal Therapeutics Market by Type
11.3.7.4.2 Japan Gastrointestinal Therapeutics Market by Route of Administration
11.3.7.4.3 Japan Gastrointestinal Therapeutics Market by Application
11.3.7.4.4 Japan Gastrointestinal Therapeutics Market by Distribution Channel
11.3.7.5 South Korea Gastrointestinal Therapeutics Market
11.3.7.5.1 South Korea Gastrointestinal Therapeutics Market by Type
11.3.7.5.2 South Korea Gastrointestinal Therapeutics Market by Route of Administration
11.3.7.5.3 South Korea Gastrointestinal Therapeutics Market by Application
11.3.7.5.4 South Korea Gastrointestinal Therapeutics Market by Distribution Channel
11.3.7.6 Rest of Asia-Pacific Gastrointestinal Therapeutics Market
11.3.7.6.1 Rest of Asia-Pacific Gastrointestinal Therapeutics Market by Type
11.3.7.6.2 Rest of Asia-Pacific Gastrointestinal Therapeutics Market by Route of Administration
11.3.7.6.3 Rest of Asia-Pacific Gastrointestinal Therapeutics Market by Application
11.3.7.6.4 Rest of Asia-Pacific Gastrointestinal Therapeutics Market by Distribution Channel
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Gastrointestinal Therapeutics Market Overview
11.4.2 Middle East and Africa Gastrointestinal Therapeutics Market Forecasts and Analysis
11.4.3 Middle East and Africa Gastrointestinal Therapeutics Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Gastrointestinal Therapeutics Market Forecasts and Analysis - By Route of Administration
11.4.5 Middle East and Africa Gastrointestinal Therapeutics Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Gastrointestinal Therapeutics Market Forecasts and Analysis - By Distribution Channel
11.4.7 Middle East and Africa Gastrointestinal Therapeutics Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Gastrointestinal Therapeutics Market
11.4.7.1.1 South Africa Gastrointestinal Therapeutics Market by Type
11.4.7.1.2 South Africa Gastrointestinal Therapeutics Market by Route of Administration
11.4.7.1.3 South Africa Gastrointestinal Therapeutics Market by Application
11.4.7.1.4 South Africa Gastrointestinal Therapeutics Market by Distribution Channel
11.4.7.2 Saudi Arabia Gastrointestinal Therapeutics Market
11.4.7.2.1 Saudi Arabia Gastrointestinal Therapeutics Market by Type
11.4.7.2.2 Saudi Arabia Gastrointestinal Therapeutics Market by Route of Administration
11.4.7.2.3 Saudi Arabia Gastrointestinal Therapeutics Market by Application
11.4.7.2.4 Saudi Arabia Gastrointestinal Therapeutics Market by Distribution Channel
11.4.7.3 U.A.E Gastrointestinal Therapeutics Market
11.4.7.3.1 U.A.E Gastrointestinal Therapeutics Market by Type
11.4.7.3.2 U.A.E Gastrointestinal Therapeutics Market by Route of Administration
11.4.7.3.3 U.A.E Gastrointestinal Therapeutics Market by Application
11.4.7.3.4 U.A.E Gastrointestinal Therapeutics Market by Distribution Channel
11.4.7.4 Rest of Middle East and Africa Gastrointestinal Therapeutics Market
11.4.7.4.1 Rest of Middle East and Africa Gastrointestinal Therapeutics Market by Type
11.4.7.4.2 Rest of Middle East and Africa Gastrointestinal Therapeutics Market by Route of Administration
11.4.7.4.3 Rest of Middle East and Africa Gastrointestinal Therapeutics Market by Application
11.4.7.4.4 Rest of Middle East and Africa Gastrointestinal Therapeutics Market by Distribution Channel
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Gastrointestinal Therapeutics Market Overview
11.5.2 South and Central America Gastrointestinal Therapeutics Market Forecasts and Analysis
11.5.3 South and Central America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Type
11.5.4 South and Central America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Route of Administration
11.5.5 South and Central America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Application
11.5.6 South and Central America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Distribution Channel
11.5.7 South and Central America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Gastrointestinal Therapeutics Market
11.5.7.1.1 Brazil Gastrointestinal Therapeutics Market by Type
11.5.7.1.2 Brazil Gastrointestinal Therapeutics Market by Route of Administration
11.5.7.1.3 Brazil Gastrointestinal Therapeutics Market by Application
11.5.7.1.4 Brazil Gastrointestinal Therapeutics Market by Distribution Channel
11.5.7.2 Argentina Gastrointestinal Therapeutics Market
11.5.7.2.1 Argentina Gastrointestinal Therapeutics Market by Type
11.5.7.2.2 Argentina Gastrointestinal Therapeutics Market by Route of Administration
11.5.7.2.3 Argentina Gastrointestinal Therapeutics Market by Application
11.5.7.2.4 Argentina Gastrointestinal Therapeutics Market by Distribution Channel
11.5.7.3 Rest of South and Central America Gastrointestinal Therapeutics Market
11.5.7.3.1 Rest of South and Central America Gastrointestinal Therapeutics Market by Type
11.5.7.3.2 Rest of South and Central America Gastrointestinal Therapeutics Market by Route of Administration
11.5.7.3.3 Rest of South and Central America Gastrointestinal Therapeutics Market by Application
11.5.7.3.4 Rest of South and Central America Gastrointestinal Therapeutics Market by Distribution Channel
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. GASTROINTESTINAL THERAPEUTICS MARKET, KEY COMPANY PROFILES
13.1. ABBOTT
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ABBVIE INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ALLERGAN
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. ASTRAZENECA
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BAYER AG
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. GLAXOSMITHKLINE PLC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. JANSSEN GLOBAL SERVICES, LLC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. PFIZER INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SALIX PHARMACEUTICALS
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. TAKEDA PHARMACEUTICAL COMPANY LIMITED
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Abbott2. AbbVie Inc.3. ALLERGAN4. AstraZeneca5. Bayer AG6. GlaxoSmithKline plc.7. Janssen Global Services, LLC8. Pfizer Inc.9. Salix Pharmaceuticals10. Takeda Pharmaceutical Company Limited
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For